Metha P, Parker RI, Galvin-Parton P, Wilson TA, Prakash D:  Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue-plasminogen activator (t-PA) activity in patients with Noonan syndrome.   (Presented at the American Society of Pediatric Hematology/Oncology - Pediatric Academic Societies Annual meeting, Baltimore, MD, May 2002). Journal of Pediatric Hematology/Oncology 24:A29,1498, 2002.

Maloney JM, Whelan MA, Parker RI, Mueller L, Prakash D: Effect of chemotherapy on T-cell populations and the maintenance of immunity to vaccinations.   (Presented at the American Society of Pediatric Hematology/Oncology - Pediatric Academic Societies Annual meeting, Seattle, WA, May 2003) Journal of Pediatric Hematology/Oncology 25:A25, 1655, 2003.

Aleyas M, Hogan L, Parker RI: Osteopenia in survivors of childhood lymphoid malignancy.   (Presented at the American Society of Pediatric Hematology/Oncology – Pediatric Academic Societies Annual meeting, Washington D.C., May 2005) Pediatr Blood Cancer 44:1166, 564, 2005.

RI Parker: Coagulation Issues in ICU patients, Chinese Society of Critical Care Medicine National Meeting, KunMing, PRC – Sept, 2004.

RI Parker: Topics in Critical Care:The Bleeding Patient. Chinese Society of Critical Care Medicine, Beijing, PRC - Sept, 2005

RI Parker: Topics in Critical Care:Blood Transfusion Therapy. Chinese Society of Critical Care Medicine, Beijing, PRC - Sept, 2005

RI Parker:   New Hematologic Therapies: Is Newer Always Better? Taiwan Society of Critical Care Medicine, Taipei, ROC – Sept, 2005

RI Parker: Gaucher Disease: Does Enzyme Replacement Therapy Work? Brasilian Society of Hematology national meeting, Rio de Janeiro, Brazil. – Nov, 2005

RI Parker: Gaucher Disease. Suffolk County Pediatric Society, Smithtown, N.Y. –Nov. 2005. 

RI Parker:   Moderator: NY Region Conference on the Management of Lysosomal Storage Diseases.   Tarrytown, N.Y. – June, 2006